So 90% of them were dealt with, I guess--approved or not--within a six-month period. That was achieved in September of 2005. That's compared with 2003, when just 16% were dealt with in that time.
On the medical device side, that has improved dramatically as well, going from 73% to 90% meeting the target in the first quarter of 2006. When you look at biological drugs, there's a 67% reduction in the backlog compared with March 2004.
Are we where we want to be perfectly? No. I think there are still some improvements. But I would say that overall there have been some dramatic increases in performance.
Sorry, Mr. Chair, but Morris is letting me know that I've misread the statistic....
So what does the 90% target mean, then, Morris, when we say we've reached 90%?